Report Cover

U.S. Minoxidil Market Size By Product (5%, 2%), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Industry Analysis Report, Country Outlook, Application Development Potential, Price Trend, Competitive Market Share & Forecast, 2021 - 2027


The U.S minoxidil market is projected to foresee commendable growth in coming years owing to numerous factors such as changes in lifestyle, rising incidence of alopecia, increased stressed levels, emotional shock, depression, and diet low in protein and iron. Other health issues such as cardiovascular diseases, cancer, arthritis, gout, high blood pressure are also known to cause hair loss problems in patients. This in turn is likely to drive the demand for minoxidil across the region.   

Minoxidil is an over-the-counter medicine for hair loss that has been approved by the U.S FDA for use among both women and men. As per the American Hair Loss Association, around two-thirds of men experience some sort of hair loss, mostly at 35 years of age. By age 50, nearly 85% of men experience hair thinning and hair loss. 

The product is mostly used to slow down balding or for stimulating hair growth. The solution belongs to a group of drugs known as vasodilators. Minoxidil usually works by relaxing as well as enlarging various small blood vessels in human body so that blood could flow through them more effortlessly.

This medication tends to work best on people under the age of 40, those who have been balding for less than 5 years. In a study published in the American Academy of Dermatology's journal, men were assigned to three types of groups namely 2% minoxidil, 5% minoxidil or placebo. Men who were using 5% minoxidil solution had around 45 per cent new hair growth in comparison to 2% group. 

In order to maintain results, minoxidil is advised to be used on a continuous basis. It is noted that stopping the use of medicine may reverse the process of new hair growth and hair loss would continue to happen. The minoxidil solution along with foam is also used to aid hair growth among women with hair thinning issues. 

In addition, minoxidil could also be taken as part of a combination therapy. It can be used along with other drugs used to treat high BP (blood pressure), or drugs used to lessen the side effects of minoxidil. In fact, numerous studies have shown that utilizing finasteride and minoxidil together is much more effective than using any of the medicine alone. 

The U.S. minoxidil market is segmented in terms of product and distribution channel.

With respect to product, the industry landscape is classified in terms of 2% as well as 5%. Among these, the 5% segment is slated to witness notable growth throughout the region owing to its ability to provide effective results.

In a 2018 study, researchers found that men who utilized 5% minoxidil solution together with LLLT (low-level laser therapy), which is an FDA approved red light device held to the hair scalp, were more pleased with their results as compared to the men who used minoxidil alone.

With regards to distribution channel, the market forks out into three separate segments of retail pharmacies, online pharmacies, and hospital pharmacies. The retail pharmacies segment is slated to witness distinguished growth owing to the flexibility they bring to the consumers to purchase affordable and quality products at their convenience.
Report Content
Chapter 1   Methodology & Scope
1.1    Market definitions
1.2    Base estimates & calculations
1.3    Forecast calculation
1.4    Data Sources
1.4.1    Primary
1.4.2    Secondary
1.4.2.1    Paid Sources
1.4.2.2    Public Sources
Chapter 2   Executive Summary
2.1    U.S. minoxidil industry 360 degree synopsis, 2016 - 2027
2.1.1    Business Trends
2.1.2    Product trends
2.1.3    Distribution channel trends
Chapter 3   US Minoxidil Industry Insights
3.1    Industry segmentation
3.2    Impact of COVID-19 on global economy
3.3    Industry ecosystem analysis
3.3.1    Raw materials
3.3.2    Manufacturers
3.3.3    Distributors
3.3.4    Distribution channel analysis
3.3.5    Profit margin trend
3.3.6    Vendor matrix
3.3.7    COVID-19 impact on value chain
3.4    Regulatory landscape
3.4.1    U.S.
3.4.1.1    Department of Health and Human Services (NDA 021812/S-009)
3.5    Raw material analysis
3.5.1    Impact of COVID-19 on raw material supply
3.6    Technology Landscape
3.6.1    Potential application scenario
3.6.1.1    Minoxidil for beard growth
3.6.1.2    Alternative minoxidil formulations
3.6.2    Formulation Process
3.6.3    Solid lipid nanoparticles
3.6.4    Propylene glycol minoxidil topical formulation for hair loss
3.7    Global alopecia industry scenario
3.7.1    Minoxidil vs other hair loss treatments
3.7.1.1    Dermatology Uses of Minoxidil
3.7.1.1.1    Androgenetic Alopecia (AGA)
3.7.1.1.2    Hair Transplant
3.7.1.1.3    Alopecia Areata
3.7.1.2    Minoxidil Side Effects
3.7.1.3    Other Hair Loss Treatments
3.7.1.3.1    Androgen-dependent medications
3.7.1.4    New users % in U.S. for 2017, 2018, 2019, and 2020
3.7.1.4.1    Demographic trends
3.7.1.4.2    Consumer buying behaviour
3.7.1.4.2.1    Unmet needs
3.7.1.4.2.2    Social & Cultural impact forces
3.7.1.4.2.3    Information search
3.7.1.4.2.4    Evaluation of alternative
3.7.1.4.2.5    Purchase decision
3.7.1.4.2.6    Post purchase evaluation
3.7.2    Impact of COVID-19 on consumer buying behavior
3.8    Industry best practices and key buying criteria
3.9    Industry impact forces
3.9.1    Growth drivers
3.9.1.1    Growing consumer spending on hair care products accompanied by expanding distribution channel
3.9.1.2    Developing personal care market along with the increasing prevalence of alopecia areata
3.9.2    Industry pitfalls & challenges
3.9.2.1    Stringent regulations along with possible side effects of minoxidil
3.10    Pricing analysis, 2016 -2027
3.10.1    Impact of COVID-19 on regional pricing
3.11    Cost structure analysis, 2020
3.12    Growth potential analysis, 2020
3.12.1    Emerging business models
3.12.1.1    Merger & Acquisition
3.12.1.2    Capacity expansion
3.12.1.1    Expansion of distribution network
3.13    Porter's analysis
3.13.1    Threat of new entrants
3.13.2    Supplier power
3.13.3    Buyer power
3.13.4    Threat of substitutes
3.14    Competitive landscape, 2020
3.14.1    Company market share analysis, 2020
3.14.2    Top players overview
3.14.3    Strategy Dashboard
3.15    PESTLE analysis
3.16    COVID-19 impact on U.S. cosmetics industry
Chapter 4   US Minoxidil Market, By Product
4.1    Key product trends
4.2    5% minoxidil
4.2.1    U.S. minoxidil market estimates and forecast from 5% minoxidil, 2016 - 2027, (Thousand Units) (USD Million)
4.3    2% minoxidil
4.3.1    U.S. minoxidil market estimates and forecast from 2% minoxidil, 2016 - 2027, (Thousand Units) (USD Million)
Chapter 5   US Minoxidil Market, By Distribution Channel
5.1    Key distribution channel trends
5.2    Hospital pharmacies
5.2.1    U.S. minoxidil market estimates and forecast from hospital pharmacies, 2016 - 2027, (Thousand Units) (USD Million)
5.3    Retail pharmacies
5.3.1    U.S. minoxidil market estimates and forecast from retail pharmacies, 2016 - 2027, (Thousand Units) (USD Million)
5.4    Online pharmacies
5.4.1    U.S. minoxidil market estimates and forecast from online pharmacies, 2016 - 2027, (Thousand Units) (USD Million)
Chapter 6   Company Profiles
6.1    Kumar Organic Products Limited
6.1.1    Business Overview
6.1.2    Financial Data
6.1.3    Product Landscape
6.1.4    Strategic Outlook
6.1.5    SWOT Analysis
6.2    Par Pharmaceuticals
6.2.1    Business Overview
6.2.2    Financial Data
6.2.3    Product Landscape
6.2.4    SWOT Analysis
6.3    Metapharmaceutical Ind. S.L.
6.3.1    Business Overview
6.3.2    Financial Data
6.3.3    Product Landscape
6.3.4    SWOT Analysis
6.4    Johnson & Johnson Consumer Inc
6.4.1    Business Overview
6.4.2    Financial Data
6.4.3    Product Landscape
6.4.4    SWOT Analysis
6.5    FLAMMA GROUP
6.5.1    Business Overview
6.5.2    Financial Data
6.5.3    Product Landscape
6.5.4    SWOT Analysis
6.6    LGM Pharma
6.6.1    Business Overview
6.6.2    Financial Data
6.6.3    Product Landscape
6.6.4    Strategic Outlook
6.6.5    Swot Analysis
6.7    Perrigo Company PLC
6.7.1    Business Overview
6.7.2    Financial Data
6.7.3    Product Landscape
6.7.4    SWOT Analysis
6.8    Renata Limited
6.8.1    Business Overview
6.8.2    Financial Data
6.8.3    Product Landscape
6.8.4    Strategic outlook
6.8.5    SWOT Analysis
6.9    Costco Wholesale Corporation
6.9.1    Business Overview
6.9.2    Financial Data
6.9.3    Product Landscape
6.9.4    SWOT Analysis
6.10    Walmart
6.10.1    Business Overview
6.10.2    Financial Data
6.10.3    Product Landscape
6.10.4    SWOT Analysis
6.11    Nanz Med Science Pharma Private Limited
6.11.1    Business Overview
6.11.2    Financial Data
6.11.3    Product Landscape
6.11.4    SWOT Analysis

Data Table TABLE 1 U.S. minoxidil market estimates & forecast, 2016 - 2020, (Thousand Units) (USD Million) TABLE 2 U.S. minoxidil market estimates & forecast, 2021 - 2027, (Thousand Units) (USD Million) TABLE 3 U.S. minoxidil market volume estimates and forecast, by product, 2016 - 2020, (Thousand Units) TABLE 4 U.S. minoxidil market volume estimates and forecast, by product, 2021 - 2027, (Thousand Units) TABLE 5 U.S. minoxidil market revenue estimates and forecast, by product, 2016 - 2020, (USD Million) TABLE 6 U.S. minoxidil market revenue estimates and forecast, by product, 2021 - 2027, (USD Million) TABLE 7 Composition of the formulation TABLE 8 U.S. minoxidil market volume estimates and forecast, by product, 2016 - 2020, (Thousand Units) TABLE 9 U.S. minoxidil market volume estimates and forecast, by distribution channel, 2021 - 2027, (Thousand Units) TABLE 10 U.S. minoxidil market revenue estimates and forecast, by distribution channel, 2016 - 2020, (USD Million) TABLE 11 U.S. minoxidil market revenue estimates and forecast, by distribution channel, 2021 - 2027, (USD Million) TABLE 12 Projections of GDP growth (%) in 2020 and 2021 TABLE 13 Projections of real GDP growth (%) in 2020 and 2021 TABLE 14 Vendor matrix TABLE 15 Bionanoplus' propylene glycol free minoxidil formulation TABLE 16 Bionanoplus' propylene glycol free minoxidil properties across a year TABLE 17 New users % in U.S. for 2017, 2018, 2019, and 2020 TABLE 18 Population remaining life expectancy TABLE 19 Industry best practices & key buying criteria TABLE 20 Industry impact forces TABLE 21 Emerging business models TABLE 22 U.S. minoxidil market estimates and forecast from 5% minoxidil, 2016 - 2020, (Thousand Units) (USD Million) TABLE 23 U.S. minoxidil market estimates & forecast from 5% minoxidil, 2021 - 2027, (Thousand Units) (USD Million) TABLE 24 U.S. minoxidil market estimates and forecast from 2% minoxidil, 2016 - 2020, (Thousand Units) (USD Million) TABLE 25 U.S. minoxidil market estimates & forecast from 2% minoxidil, 2021 - 2027, (Thousand Units) (USD Million) TABLE 26 U.S. minoxidil market estimates and forecast from 5% minoxidil, 2016 - 2020, (Thousand Units) (USD Million) TABLE 27 U.S. minoxidil market estimates & forecast from hospital pharmacies, 2021 - 2027, (Thousand Units) (USD Million) TABLE 28 U.S. minoxidil market estimates and forecast from retail pharmacies, 2016 - 2020, (Thousand Units) (USD Million) TABLE 29 U.S. minoxidil market estimates & forecast from retail pharmacies, 2021 - 2027, (Thousand Units) (USD Million) TABLE 30 U.S. minoxidil market estimates and forecast from online pharmacies, 2016 - 2020, (Thousand Units) (USD Million) TABLE 31 U.S. minoxidil market estimates & forecast from online pharmacies, 2021 - 2027, (Thousand Units) (USD Million) Charts & Figures FIG. 1 U.S. minoxidil market revenue share, by product, 2016, (% share) FIG. 2 U.S. minoxidil industry 360 degree synopsis, 2016 - 2027 FIG. 3 Industry segmentation FIG. 4 Industry ecosystem analysis FIG. 5 Global urban population by region, 2007 & 2030 FIG. 6 Global Muslim population by region (million), 2016 FIG. 7 Global hair care market revenue (USD Billion), 2010-2020 FIG. 8 Global personal care market revenue (USD Billion), 2010-2020 FIG. 9 Cost structure analysis, 2020 FIG. 10 Growth potential analysis, 2020 FIG. 11 Porter's analysis FIG. 12 Company market share analysis, 2020 FIG. 13 PESTLE analysis FIG. 14 SWOT Analysis, Kumar Organic Products Limited FIG. 15 SWOT Analysis, Par Pharmaceuticals FIG. 16 SWOT Analysis, Metapharmaceutical Ind. S.L. FIG. 17 SWOT Analysis, Johnson & Johnson FIG. 18 SWOT Analysis, FLAMMA GROUP FIG. 19 Swot Analysis, LGM Pharma FIG. 20 SWOT Analysis, Perrigo Company Plc FIG. 21 SWOT Analysis, Renata Limited FIG. 22 SWOT Analysis, Costco Wholesale Corporation FIG. 23 SWOT Analysis, Walmart FIG. 24 SWOT Analysis, Nanz Med Science Pharma Private Limited

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: Global Market Insights, Inc.
Chat with us